HSBC Holdings
RCKT icon

HSBC Holdings’s Rocket Pharmaceuticals RCKT Stock Holding History

HSBC Holdings’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,581
Closed -$48.6K – 3168
2025
Q4 		$48.6K Buy
+13,581
New +$46.5K ﹤0.01% 2865
2025
Q2 		– Sell
-10,583
Closed -$69.1K – 3205
2025
Q1 		$69.1K Buy
+10,583
New +$105K ﹤0.01% 2865
2024
Q2 		– Sell
-8,048
Closed -$217K – 3131
2024
Q1 		$217K Buy
+8,048
New +$229K ﹤0.01% 2647
2022
Q4 		– Sell
-11,412
Closed -$177K – 3167
2022
Q3 		$177K Buy
+11,412
New +$178K ﹤0.01% 2657
2019
Q4 		– Sell
-10,687
Closed -$125K – 3161
2019
Q3 		$125K Buy
+10,687
New +$133K ﹤0.01% 2957

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Citigroup
Citigroup New York $157B AUM 32.99% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MC
Maverick Capital Dallas, Texas $8.6B AUM 48.76% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return